Search Results - "Yuka KAGAWA"

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    Directional Transcellular Transport of Bisoprolol in P-glycoprotein-expressed LLC-GA5-COL150 Cells but not in Renal Epithelial LLC-PK1 Cells

    Directional Transcellular Transport of Bisoprolol in P-glycoprotein-expressed LLC-GA5-COL150 Cells but not in Renal Epithelial LLC-PK1 Cells by Tahara, Katsutoshi, Kagawa, Yuka, Takaai, Mari, Taguchi, Masato, Hashimoto, Yukiya

    Published in Drug metabolism and pharmacokinetics (01-01-2008)
    “…To evaluate the mechanism responsible for the tubular secretion of bisoprolol, we compared transcellular transport of bisoprolol with that of…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    Pharmacokinetics and Pharmacodynamics of Bisoprolol in Rats with Bilateral Ureter Ligation-induced Renal Failure

    Pharmacokinetics and Pharmacodynamics of Bisoprolol in Rats with Bilateral Ureter Ligation-induced Renal Failure by Tahara, Katsutoshi, Saigusa, Katsuya, Kagawa, Yuka, Taguchi, Masato, Hashimoto, Yukiya

    Published in Drug metabolism and pharmacokinetics (01-01-2006)
    “…The effect of renal failure on the pharmacokinetics and pharmacodynamics of bisoprolol was investigated in bilateral ureter-ligated (BUL) rats. The blood…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  3. 3
    An Open-Label, Multicenter, Single-Arm, Phase I Dose Escalation Study of OP-2100, an Orally Bioavailable Prodrug of Decitabine, for Patients with Relapsed or Refractory Higher-Risk Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia

    An Open-Label, Multicenter, Single-Arm, Phase I Dose Escalation Study of OP-2100, an Orally Bioavailable Prodrug of Decitabine, for Patients with Relapsed or Refractory Higher-Risk Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia by Kimura, Shinya, Usuki, Kensuke, Ichinohe, Tatsuo, Ikezoe, Takayuki, Kuroda, Junya, Kasahara, Senji, Okamoto, Sho, Iizuka, Hiromitsu, Ureshino, Hiroshi, Watanabe, Tatsuro, Ro, Tokihiro, Endo, Kosuke, Kagawa, Yuka, Kurahashi, Yuki, Naito, Toshiki, Yamauchi, Takahiro

    Published in Blood (02-11-2023)
    “…Hypomethylating agents (HMA) are commonly used to treat high-risk myelodysplastic syndromes (MDS) and chronic myelomonocytic leukemia (CMML).Decitabine (DEC),…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  4. 4
    Directional Transcellular Transport of Bisoprolol in P-glycoprotein-expressed LLC-GA5-COL150 Cells, but not in Renal Epithelial LLC-PK1 Cells

    Directional Transcellular Transport of Bisoprolol in P-glycoprotein-expressed LLC-GA5-COL150 Cells, but not in Renal Epithelial LLC-PK1 Cells by Katsutoshi TAHARA, Yuka KAGAWA, Mari TAKAAI, Masato TAGUCHI, Yukiya HASHIMOTO

    “…[Summary] To evaluate the mechanism responsible for the tubular secretion of bisoprolol, we compared transcellular transport of bisoprolol with that of…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  5. 5
    Pharmacokinetics and Pharmacodynamics of Bisoprolol in Rats with Bilateral Ureter Ligation-induced Renal Failure

    Pharmacokinetics and Pharmacodynamics of Bisoprolol in Rats with Bilateral Ureter Ligation-induced Renal Failure by Katsutoshi TAHARA, Katsuya SAIGUSA, Yuka KAGAWA, Masato TAGUCHI, Yukiya HASHIMOTO

    “…The effect of renal failure on the pharmacokinetics and pharmacodynamics of bisoprolol was investigated in bilateral ureter-ligated (BUL) rats. The blood…”
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: